Analyst Ratings for ISIS Pharmaceuticals (ISIS)

ISIS Rating Summary

ISIS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ISIS
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $50.80 (+46.9%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
1/22/2014 Deutsche Bank
» Updated 3/13/2014
New Coverage Buy
(N/A)
60.00
(N/A)
48.00 34.57 -27.98% Details
11/27/2013 Piper Jaffray Upgrade Neutral
(Underweight)
N/A
(N/A)
38.14 34.57 -9.36% Details
Like ISIS Ratings? Also take a look at SNY, SAN, AZN, GSK

ISIS Ratings News